Company news

Insulet Corporation news in 2020

Insulet Corporation's news releases, calls and decks from 2020, newest first.

View company

Insulet to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference

December 20, 2020

Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year

November 3, 2020

Insulet Raises Awareness for Diabetes Throughout November

November 1, 2020

Insulet Recognized as Global Impact Corporate Hero and Manufacturer of the Year

October 28, 2020

Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors

October 19, 2020

Insulet to Announce Third Quarter 2020 Financial Results on November 4, 2020

October 4, 2020

Insulet Expands its Offering of Omnipod DASH® Insulin Management System

September 20, 2020

Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year

August 5, 2020

Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020

June 28, 2020

Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint

June 23, 2020

Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions

June 10, 2020

Insulet Resumes Pivotal Study of its Next-Generation Product - Omnipod, Powered by Horizon™

June 4, 2020

Insulet Corporation Announces Pricing of $500 Million Public Offering of Common Stock

May 11, 2020

Insulet Corporation Announces Plans for Public Offering of Common Stock

May 11, 2020

Insulet Reports First Quarter 2020 Revenue Increase of 24% Year-Over-Year

May 6, 2020

Insulet Expands its U.S. Financial Assistance Program for Current Users Impacted by COVID-19

April 15, 2020

Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020

April 5, 2020

Insulet’s Omnipod DASH™ System Voted 2020 Product of the Year in Health Systems Category by 40,000 U.S. Consumers

March 4, 2020

Insulet Provides Update on Pivotal Study of Omnipod Horizon™

March 1, 2020

Insulet Reports Full Year 2019 Revenue of $738.2 Million, an Increase of 31%, and Fourth Quarter 2019 Revenue of $209.4 Million, an Increase of 27% Year-Over-Year

February 24, 2020

Insulet Issues Medical Device Correction Regarding its Omnipod DASH™ Insulin Management System

February 12, 2020

Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020

January 5, 2020

Calls in 2020